Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Share News (PLP)

  • There is currently no data for PLP

Friday broker round-up

Fri, 26th Oct 2018 12:16
(Sharecast News) - Polypipe: Numis upgrades to buy with a target price of 450p.Elementis: Berenberg reiterates buy with a target price of 260p.Centrica: Berenberg reiterates buy with a target price of 170p.Lloyds Banking Group: Deutsche Bank reiterates buy with a target price of 77p.WPP: Deutsche Bank reiterates hold with a target price of 1,160p.CPP Group: Liberum initiates buy with a target price of 15p.IAG: Liberum reiterates buy with a target price of 875p.CareTech: Liberum reiterates buy with a target price of 525p.Hastings: Barclays reiterates equal weight with a target price of 243p.RELX: Barclays overweight with a target price of 1,755p.Vivo Energy: JP Morgan reiterates overweight with a target price of 160p.Fresnillo: RBC Capital Markets reiterates top pick with a target price of 1,300p.Whitbread: Canaccord downgrades to hold with a target price of 4,500p.RBS: Jefferies reiterates buy with a target price of 358p.TUI: UBS downgrades to sell with a target price of 1,200p.ConvaTec: UBS downgrades to neutral with a target price of 150p.OneSavings Bank: Numis upgrades to buy with a target price of 475p.

Related News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
29 mins ago

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

IN BRIEF: Relx launches GBP200 million share buyback programme
1 hour ago

IN BRIEF: Relx launches GBP200 million share buyback programme

Relx PLC - London-based provider of business, scientific and legal information - Commences a new share buyback scheme worth GBP200 million, and runs u...

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
2 hours ago

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

PLP.L News

Polypipe FY revenues slump amid Covid-19
16 Mar 2021

Polypipe FY revenues slump amid Covid-19

(Sharecast News) - Plastics company Polypipe said on Tuesday that full-year revenues had declined in 2020 on impacts felt from the Covid-19 pandemic.

Polypipe says rebounding from Covid hit; plans to become Genuit Group
16 Mar 2021

Polypipe says rebounding from Covid hit; plans to become Genuit Group

Polypipe says rebounding from Covid hit; plans to become Genuit Group

UK earnings, trading statements calendar - next 7 days
9 Mar 2021

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

BROKER RATINGS: SocGen downgrades Pearson to Hold from Buy
9 Mar 2021

BROKER RATINGS: SocGen downgrades Pearson to Hold from Buy

BROKER RATINGS: SocGen downgrades Pearson to Hold from Buy

Berenberg raises target price on Polypipe
15 Feb 2021

Berenberg raises target price on Polypipe

(Sharecast News) - Analysts at Berenberg raised their target price on plastics pipe company Polypipe from 540.0p to 610.0p on Monday, stating recent a...

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket
15 Feb 2021

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

Friday broker round-up
12 Feb 2021

Friday broker round-up

(Sharecast News) - RELX: Berenberg reiterates hold with a target price of 1,816p.

BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy
12 Feb 2021

BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy

BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy